Your Partner. For science. For life.
Battling chronic ailments. Evolving science. Improving quality of life. Even helping people get a better night’s sleep. Our portfolio companies are positively impacting the world every day with their visionary people and life-changing products.
What they do.
Provide fresh and cyropreserved hepatocytes, or liver cells, and other products for pharmaceutical and CRO industries.
PBM Capital founded TRL and oversaw operations until 2016 when it sold the business to Lozo (SIX:LONN).
Achievement of Note:
TRL is widely recognized as world’s fastest growing hepatocyte provider.
How they‘re improving the quality of peoples lives:
TRL helps make drugs better and safer for your liver, supplying the hepatocytes that are used for testing drug-drug interactions, toxicity and a number of other evaluations.